List view / Grid view
Sanofi’s new Diversity, Equity & Inclusion (DE&I) Board, and accompanying…
Sanofi’s new Diversity, Equity & Inclusion (DE&I) Board, and accompanying global Employee Resource Group (ERG) framework, will support the delivery of the company’s DE&I strategy.
A long-term strategic business collaboration to co-develop and commercialize an…
19 March 2014 | By Sanofi
A long-term strategic business collaboration to co-develop and commercialize an innovative vaccine against pneumococcal infection to address global public-health needs...
Prequalification makes the vaccine eligible for purchase by United Nations…
3 September 2013 | By Sanofi
Prequalification makes the vaccine eligible for purchase by United Nations Agencies...
Company also expands injectable polio vaccine production capacity...
24 April 2013 | By Sanofi Pasteur
Company also expands injectable polio vaccine production capacity...
Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine...
22 April 2013 | By Sanofi Pasteur
Hexyon/Hexacima is the only fully liquid, ready-to-use, 6-in-1 pediatric vaccine...
Creation of a new state-of-the-art industrial platform at Genzyme’s unit…
25 March 2013 | By Sanofi
Creation of a new state-of-the-art industrial platform at Genzyme’s unit in Lyon...
The EMA recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric…
22 February 2013 | By Sanofi
The EMA recommended market approval for Sanofi Pasteur’s 6-in-1 pediatric vaccine...
Sanofi Pasteur, announced that HexaximTM received a positive scientific opinion...
22 June 2012 | By Sanofi Pasteur
Sanofi Pasteur, announced that HexaximTM received a positive scientific opinion...
Approval of IMOVAX® POLIO by Japanese health authorities...
27 April 2012 | By Sanofi
Approval of IMOVAX® POLIO by Japanese health authorities...
Brazil has chosen to introduce injectable polio vaccine in its…
18 January 2012 | By Sanofi Pasteur
Brazil has chosen to introduce injectable polio vaccine in its national immunization program...
Sanofi Pasteur, announced that the WHO has granted prequalification to…
23 June 2011 | By Sanofi Pasteur
Sanofi Pasteur, announced that the WHO has granted prequalification to its Typhim Vi® polysaccharide typhoid vaccine...
The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone…
10 May 2011 | By Sanofi Pasteur
The FDA approved Sanofi Pasteur’s sBLA for licensure of Fluzone Intradermal...
